Focus on Atrial Fibrillation: Understanding the Dominant Application Driving Significant Demand in the Apixaban Market
The Apixaban market’s valuation and growth are overwhelmingly driven by its primary indication: the prevention of stroke and systemic embolism in patients diagnosed with non-valvular atrial fibrillation (AF). Atrial fibrillation is the most prevalent sustained cardiac arrhythmia, and its associated risk of stroke is substantial and life-threatening. Effective anticoagulation is mandatory...
0 Commenti 0 condivisioni 363 Views 0 Anteprima